NASDAQ Companies

SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]

Metuchen, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) — Feutune Light Acquisition Corporation (NASDAQ: FLFV) (the “Company”), a blank check company […]

CINCINNATI, Dec. 21, 2023 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company […]

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating […]

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]

– SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); […]

SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) — DMK Pharmaceuticals Corporation (Nasdaq: DMK) (“DMK”), a commercial stage neuro-biotech company primarily […]

Roseland, NJ, Dec. 21, 2023 (GLOBE NEWSWIRE) — The NFT Gaming Company, Inc. (“NFTG” or the “Company”), a company developing […]

CULVER CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global […]

Designation is based on Phase 1/2 safety and efficacy data in patients with Human Epidermal Growth Factor Receptor 2 (“HER2”)-expressing […]